A Phase II Open-Label Multicenter Study Evaluating The Safety And Efficacy Of Neoadjuvant And Adjuvant Tiragolumab Plus Atezolizumab With Or Without Platinum-Based Chemotherapy In Patients With Previously Untreated Locally Advanced Resectable Stage II, IIIa Or Select IIIb Non-Small Cell Lung Cancer

Brief Summary

Type:
Lung Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04832854

Study #:
STUDY00148512

Start Date:
Nov 13, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04832854

View Complete Trial Details & Eligibility at ClinicalTrials.gov